NEWS
Annual general meeting
11/06/12
Mr Ingemar Kihlström was elected to the Board of Directors and succeeds Mr Masoud Khayyami as Chairman.Read more...
Successful surveillance audit
08/06/12
SpectraCure maintains ISO 13485/MDD Annex 5 Quality Management System certificate. Read more...
Advanced Cancer Treatment With IDOSE®
SpectraCure develops advanced methods for treatment planning and laser light dose management for cancer treatment. The method, interstitial photodynamic therapy (PDT), utilizes a laser light source and a photosensitizing drug. This technology is suitable for internal cancer tumours such as prostate cancer and pancreatic cancer. SpectraCure has developed its sophisticated software IDOSE®, as well as medical laser devices for this purpose.
How does it work?
The method works by combining a light-activated drug - photosensitiser - with light of a certain wavelength. This results in a photochemical reaction that causes cell death. It is important to control the laser light dose to ensure that sufficient light dose is given and that only the cancer tumour is destroyed.
Our Technology
SpectraCure has developed and patented technology for delivering laser light to cancer tumours for PDT, and the dose management system IDOSE® that provides the possibility for safe, accurate, and efficient interstitial PDT of internal tumours. Read More...
Watch the video
